Is phased implementation of HPV testing and triage with dual staining the way to transform organized cytology screening?

The European response to the WHO call to eliminate cervical cancer as a public health problem

(2020) Marc Arbyn et al.   INTERNATIONAL JOURNAL OF CANCER

WHO launches strategy to accelerate elimination of cervical cancer

(2020) Manjulika Das   LANCET ONCOLOGY

Clinical Evaluation of Human Papillomavirus Screening With p16/Ki-67 Dual Stain Triage in a Large Organized Cervical Cancer Screening Program

(2019) Nicolas Wentzensen et al.   JAMA Internal Medicine

OUP accepted manuscript

(2018)   AMERICAN JOURNAL OF CLINICAL PATHOLOGY

A report on the status of vaccination in Europe

(2018) Shazia Sheikh et al.   VACCINE

‘It has saved thousands of lives, so why change it?’ Content analysis of objections to cervical screening programme changes in Australia

(2018) Helena M Obermair et al.   BMJ Open

Triaging HPV-positive women with p16/Ki-67 dual-stained cytology: Results from a sub-study nested into the ATHENA trial

(2017) Thomas C. Wright et al.   GYNECOLOGIC ONCOLOGY

Triage of HPV positive women in cervical cancer screening

(2016) Nicolas Wentzensen et al.   JOURNAL OF CLINICAL VIROLOGY

Impact of provider-patient communication on cancer screening adherence: A systematic review

(2016) Emily B. Peterson et al.   PREVENTIVE MEDICINE

Bethesda 2014: improving on a paradigm shift

(2015) D. C. Wilbur et al.   CYTOPATHOLOGY

Primary cervical cancer screening with human papillomavirus: End of study results from the ATHENA study using HPV as the first-line screening test

(2015) Thomas C. Wright et al.   GYNECOLOGIC ONCOLOGY

Liquid-Based Cytology and Human Papillomavirus Testing to Screen for Cervical Cancer: A Systematic Review for the U.S. Preventive Services Task Force

(2013) Evelyn P. Whitlock et al.   ANNALS OF INTERNAL MEDICINE

Efficacy of HPV-based screening for prevention of invasive cervical cancer: follow-up of four European randomised controlled trials

(2013) Guglielmo Ronco et al.   LANCET

Triaging Pap cytology negative, HPV positive cervical cancer screening results with p16/Ki-67 Dual-stained cytology

(2011) K. Ulrich Petry et al.   GYNECOLOGIC ONCOLOGY

Human papillomavirus testing for the detection of high-grade cervical intraepithelial neoplasia and cancer: final results of the POBASCAM randomised controlled trial

(2011) Dorien C Rijkaart et al.   LANCET ONCOLOGY

Long-term Absolute Risk of Cervical Intraepithelial Neoplasia Grade 3 or Worse Following Human Papillomavirus Infection: Role of Persistence

(2010) S. K. Kjaer et al.   JNCI-Journal of the National Cancer Institute

Guidelines for human papillomavirus DNA test requirements for primary cervical cancer screening in women 30 years and older

(2008) Chris J.L.M. Meijer et al.   INTERNATIONAL JOURNAL OF CANCER

Screening-Preventable Cervical Cancer Risks: Evidence From a Nationwide Audit in Sweden

(2008) B. Andrae et al.   JNCI-Journal of the National Cancer Institute